{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:26:35Z","timestamp":1761546395980,"version":"build-2065373602"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Immunotherapy has reshaped the treatment of several cancers, yet patient responses remain highly variable, partly due to differences in immune competence. In soft tissue sarcomas (STS), the immune landscape is poorly characterized, limiting the development of prognostic markers and immune-based therapeutic strategies. This study aimed to comprehensively profile circulating and tumor-infiltrating cytotoxic lymphocyte populations in STS. Peripheral blood from patients and healthy donors was analyzed by multiparametric flow cytometry combined with AI-assisted unsupervised clustering, enabling the identification of both conventional and unconventional subsets. In a pilot cohort, tumor-infiltrating lymphocytes were evaluated using the same approach to explore systemic\u2013local immune compartmentalization. STS patients displayed systemic immune imbalance with increased CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells and reduced NK cells and CD161\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells, consistent with overall immunosuppression. Several unconventional populations showed prognostic associations: elevated CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u03b3\u03b4 T cells and CD4\n                    <jats:sup>+<\/jats:sup>\n                    NKT-like cells correlated with poorer survival, whereas CD8\n                    <jats:sup>+<\/jats:sup>\n                    NKT-like cells were enriched in immune-competent patients and linked to better outcomes, suggesting potential protective functions. Pilot tumor analyses identified \u03b3\u03b4 NKT-like cells that were nearly absent from circulation, suggesting their selective enrichment within the tumor microenvironment. Together, these findings highlight the contribution of rarely profiled cytotoxic lymphocytes to systemic immune fitness and disease outcome in STS. Importantly, despite clinical and histological heterogeneity, patients showed consistent immune alterations, suggesting shared immunological features across STS subtypes. While limited by small tumor sample size and lack of functional assays, this study provides proof-of-concept that immune-based profiling can uncover novel prognostic markers and candidate populations of therapeutic relevance. Future work in larger, longitudinal cohorts, coupled with functional characterization, will be essential to validate these subsets and to define their role in STS immune surveillance and responsiveness to immunotherapy.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1677408","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:21:26Z","timestamp":1761546086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-assisted peripheral immune profiling reveals unconventional lymphocyte signatures associated with prognosis in soft tissue sarcoma patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Jani Sofia","family":"Almeida","sequence":"first","affiliation":[]},{"given":"Luana Madalena","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Couceiro","sequence":"additional","affiliation":[]},{"given":"Vera","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Ruben","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Freitas-Tavares","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Santos-Rosa","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Casanova","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Rodrigues-Santos","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O'Brien","year":"2022","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101992","article-title":"Deciphering immune predictors of immunotherapy response: A multiomics approach at the pan-cancer level","volume":"6","author":"Li","year":"2025","journal-title":"Cell Rep Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011242","article-title":"Immune status and selection of patients for immunotherapy in myeloma: a proposal","volume":"8","author":"Dhodapkar","year":"2024","journal-title":"Blood Adv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s40425-019-0799-2","article-title":"Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential","volume":"7","author":"Nixon","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03398-5","article-title":"Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data","volume":"31","author":"Yoo","year":"2025","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2024.04.008","article-title":"Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer","volume":"42","author":"Dyikanov","year":"2024","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061305","article-title":"The peripheral immune landscape of breast cancer: clinical findings and in vitro models for biomarker discovery","volume":"13","author":"Batalha","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e000363","DOI":"10.1136\/jitc-2019-000363","article-title":"High-dimensional immune-profiling in cancer: implications for immunotherapy","volume":"8","author":"Chuah","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: Hallmarks of systemic disease","author":"Swanton","year":"2024","journal-title":"Cell"},{"volume-title":"WHO classification of tumours series","year":"2020","article-title":"Soft tissue and bone tumours","key":"B12"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1391840","article-title":"Peripheral immune profiling of soft tissue sarcoma: perspectives for disease monitoring","volume":"15","author":"Almeida","year":"2024","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1321584","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"14","author":"Mei","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214972","article-title":"Does the use of peripheral immune- related markers indicate whether to administer pazopanib, trabectedin, or eribulin to advanced soft tissue sarcoma patients","volume":"10","author":"Shimada","year":"2021","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16511","article-title":"Neutrophil-, monocyte- and platelet-to-lymphocyte ratios, and absolute lymphocyte count for diagnosis of Malignant soft-tissue tumors","volume":"43","author":"Mihara","year":"2023","journal-title":"Anticancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.633910","article-title":"Unsupervised analysis of flow cytometry data in a clinical setting captures cell diversity and allows population discovery","volume":"12","author":"Baumgaertner","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1026416","article-title":"Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes","volume":"13","author":"Bechi Genzano","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14040420","article-title":"Validation of artificial intelligence (AI)-assisted flow cytometry analysis for immunological disorders","volume":"14","author":"Lu","year":"2024","journal-title":"Diagnost (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw191","article-title":"flowAI: automatic and interactive anomaly discerning tools for flow cytometry data","volume":"32","author":"Monaco","year":"2016","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1371559","article-title":"Circulating T cells: a promising biomarker of anti-PD-(L)1 therapy","volume":"15","author":"Hou","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.ccell.2023.11.005","article-title":"Phenotypic signatures of circulating neoantigen- reactive CD8+ T cells in patients with metastatic cancers","volume":"41","author":"Yossef","year":"2023","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03375-x","article-title":"Natural killer cells: the immune frontline against circulating tumor cells","volume":"44","author":"Masmoudi","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.07.038","article-title":"Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma","volume":"37","author":"Shafer","year":"2013","journal-title":"Leuk Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.107392","article-title":"Prognostic value of circulating lymphocyte subsets in cervical cancer following postoperative radiotherapy","volume":"22","author":"Wang","year":"2025","journal-title":"Int J Med Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02343-7","article-title":"Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile","volume":"68","author":"Krijgsman","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143592","article-title":"Circulating natural killer cells as prognostic value for non-small-cell lung cancer patients treated with immune checkpoint inhibitors: correlation with sarcopenia","volume":"15","author":"Tenuta","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural Killer cells at the frontline in the fight against cancer","volume":"15","author":"Co\u00ebnon","year":"2024","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613204","article-title":"CD8+CD161+ T-cells: cytotoxic memory cells with high therapeutic potential","volume":"11","author":"Konduri","year":"2021","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01886.x","article-title":"CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver","volume":"129","author":"Iiai","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e008694","DOI":"10.1136\/jitc-2023-008694","article-title":"Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer","volume":"12","author":"Chen","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41698-020-00133-4","article-title":"The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma","volume":"4","author":"Li","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00452-4","article-title":"\u03b3\u03b4 T cells in tissue physiology and surveillance","volume":"21","author":"Ribot","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00576-0","article-title":"Function of \u03b3\u03b4 T cells in tumor immunology and their application to cancer therapy","volume":"53","author":"Park","year":"2021","journal-title":"Exp Mol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2583","article-title":"Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells","volume":"105","author":"Fischer","year":"2005","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"eade3525","DOI":"10.1126\/sciimmunol.ade3525","article-title":"NK-like CD8+ \u03b3\u03b4 T cells are expanded in persistent Mycobacterium tuberculosis infection","volume":"8","author":"Roy Chowdhury","year":"2023","journal-title":"Sci Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.596489","article-title":"Corrigendum: gamma\/delta T cells in the course of healthy human pregnancy: cytotoxic potential and the tendency of CD8 expression make CD56+ \u03b3\u03b4T cells a unique lymphocyte subset","volume":"12","author":"N\u00f6renberg","year":"2022","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01855-4","article-title":"Perinatal thymic-derived CD8\u03b1\u03b2- expressing \u03b3\u03b4 T cells are innate IFN-\u03b3 producers that expand in IL-7R-STAT5B-driven neoplasms","volume":"25","author":"Sumaria","year":"2024","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2007.05.002","article-title":"Invariant NKT and NKT-like lymphocytes: Two different T cell subsets that are differentially affected by ageing","volume":"42","author":"Peralbo","year":"2007","journal-title":"Exp Gerontol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032743","article-title":"Natural killer T-like cells: immunobiology and role in disease","volume":"24","author":"Almeida","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep14124","article-title":"CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1089\/107999001753289514","article-title":"Induction of cytotoxic CD8+CD56+ T cells from human thymocytes by interleukin-15","volume":"21","author":"Thulesen","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336321","article-title":"Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity","volume":"118","author":"Pievani","year":"2011","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02493","article-title":"NKT-like (CD3+CD56+) cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors","volume":"10","author":"Almeida","year":"2019","journal-title":"Front Immunol"},{"key":"B47","article-title":"NKT-like cells are expanded in solid tumour patients","author":"Zdrazilova-Dubska","year":"2012","journal-title":"Klin Onkol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.2002068","article-title":"PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma","volume":"10","author":"Tao","year":"2021","journal-title":"Oncoimmunology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00892","article-title":"CD56 in the immune system: more than a marker for cytotoxicity","volume":"8","author":"Van Acker","year":"2017","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1023\/a:1015415928521","article-title":"Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice","volume":"22","author":"Verneris","year":"2002","journal-title":"J Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13287-024-03869-z","article-title":"Cytokine-induced killer cells: new insights for therapy of hematologic Malignancies","volume":"15","author":"Ghanbari Sevari","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-infiltrating natural killer cells","volume":"11","author":"C\u00f3zar","year":"2021","journal-title":"Cancer Discov"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01884-z","article-title":"Pan- cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping","volume":"25","author":"Netskar","year":"2024","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01420-14","article-title":"High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression","volume":"88","author":"Ahmad","year":"2014","journal-title":"J Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e173602","DOI":"10.1172\/JCI173602","article-title":"Induced CD8\u03b1 identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation","volume":"134","author":"Cubitt","year":"2024","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4912","article-title":"Isopentenyl pyrophosphate-activated CD56+ \u03b3\u03b4 T lymphocytes display potent antitumor activity toward human squamous cell carcinoma","volume":"14","author":"Alexander","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e953410","DOI":"10.4161\/21624011.2014.953410","article-title":"Stress-related and homeostatic cytokines regulate V\u03b39V\u03b42 T-cell surveillance of mevalonate metabolism","volume":"3","author":"Gruenbacher","year":"2014","journal-title":"Oncoimmunology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12735","article-title":"Interleukin-18 activates V\u03b39V\u03b4+ T cells from HIV-positive individuals: recovering the response to phosphoantigen","volume":"151","author":"Murday","year":"2017","journal-title":"Immunology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10484","article-title":"Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"B61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clim.2004.05.003","article-title":"Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver","volume":"113","author":"Kenna","year":"2004","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677408\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:21:27Z","timestamp":1761546087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677408\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2025.1677408"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1677408","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"article-number":"1677408"}}